A detailed history of Fiduciary Trust CO transactions in Eli Lilly & CO stock. As of the latest transaction made, Fiduciary Trust CO holds 8,561 shares of LLY stock, worth $6.39 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
8,561
Previous 8,039 6.49%
Holding current value
$6.39 Million
Previous $7.28 Million 4.2%
% of portfolio
0.11%
Previous 0.11%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$772.14 - $960.02 $403,057 - $501,130
522 Added 6.49%
8,561 $7.58 Million
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $664,705 - $833,589
917 Added 12.88%
8,039 $7.28 Million
Q1 2024

May 13, 2024

BUY
$592.2 - $792.28 $52,705 - $70,512
89 Added 1.27%
7,122 $5.54 Million
Q4 2023

Feb 12, 2024

SELL
$525.19 - $619.13 $129,196 - $152,305
-246 Reduced 3.38%
7,033 $4.1 Million
Q3 2023

Nov 14, 2023

SELL
$434.7 - $599.3 $163,881 - $225,936
-377 Reduced 4.92%
7,279 $3.91 Million
Q2 2023

Aug 01, 2023

BUY
$350.74 - $468.98 $69,797 - $93,327
199 Added 2.67%
7,656 $3.59 Million
Q1 2023

May 15, 2023

BUY
$310.63 - $364.82 $193,833 - $227,647
624 Added 9.13%
7,457 $2.56 Million
Q4 2022

Feb 13, 2023

BUY
$321.55 - $374.67 $148,877 - $173,472
463 Added 7.27%
6,833 $2.5 Million
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $96,948 - $110,483
327 Added 5.41%
6,370 $2.06 Million
Q2 2022

Aug 12, 2022

SELL
$278.73 - $327.27 $32,332 - $37,963
-116 Reduced 1.88%
6,043 $1.96 Million
Q1 2022

May 12, 2022

SELL
$234.69 - $291.66 $58,907 - $73,206
-251 Reduced 3.92%
6,159 $1.76 Million
Q4 2021

Feb 14, 2022

SELL
$224.85 - $279.04 $32,828 - $40,739
-146 Reduced 2.23%
6,410 $1.77 Million
Q3 2021

Nov 12, 2021

SELL
$221.6 - $272.71 $45,428 - $55,905
-205 Reduced 3.03%
6,556 $1.51 Million
Q2 2021

Aug 16, 2021

SELL
$180.55 - $233.54 $438,917 - $567,735
-2,431 Reduced 26.45%
6,761 $1.55 Million
Q1 2021

May 19, 2021

SELL
$164.32 - $212.72 $33,849 - $43,820
-206 Reduced 2.19%
9,192 $1.72 Million
Q4 2020

Jan 26, 2021

SELL
$130.46 - $172.63 $97,975 - $129,645
-751 Reduced 7.4%
9,398 $1.59 Million
Q3 2020

Nov 13, 2020

SELL
$146.22 - $169.13 $185,991 - $215,133
-1,272 Reduced 11.14%
10,149 $1.5 Million
Q2 2020

Aug 13, 2020

BUY
$136.42 - $164.18 $8,867 - $10,671
65 Added 0.57%
11,421 $1.88 Million
Q1 2020

May 15, 2020

BUY
$119.05 - $147.35 $43,334 - $53,635
364 Added 3.31%
11,356 $1.58 Million
Q4 2019

Feb 04, 2020

SELL
$106.92 - $132.43 $35,818 - $44,364
-335 Reduced 2.96%
10,992 $1.45 Million
Q3 2019

Nov 12, 2019

SELL
$106.79 - $116.16 $26,163 - $28,459
-245 Reduced 2.12%
11,327 $1.27 Million
Q2 2019

Aug 14, 2019

BUY
$110.79 - $129.32 $96,387 - $112,508
870 Added 8.13%
11,572 $1.28 Million
Q1 2019

May 07, 2019

BUY
$111.31 - $131.02 $63,335 - $74,550
569 Added 5.62%
10,702 $1.39 Million
Q4 2018

Jan 29, 2019

BUY
$105.9 - $118.64 $7,942 - $8,898
75 Added 0.75%
10,133 $1.17 Million
Q2 2018

Aug 03, 2018

BUY
$75.7 - $86.88 $44,435 - $50,998
587 Added 6.2%
10,058 $858,000
Q1 2018

May 08, 2018

SELL
$74.21 - $87.6 $7,495 - $8,847
-101 Reduced 1.06%
9,471 $733,000
Q4 2017

Jan 29, 2018

BUY
$81.94 - $87.89 $13,356 - $14,326
163 Added 1.73%
9,572 $808,000
Q3 2017

Nov 02, 2017

BUY
$77.07 - $85.54 $725,151 - $804,845
9,409
9,409 $805,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $709B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Fiduciary Trust CO Portfolio

Follow Fiduciary Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fiduciary Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Fiduciary Trust CO with notifications on news.